Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Resistant Langerhans Cell Histiocytosis With Etanercept (ENBREL, IMMUNEX, SEATTLE)

NCT00048373 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00048373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00048373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Resistant Langerhans Cell Histiocytosis With Etanercept (ENBREL, IMMUNEX, SEATTLE)
Lead sponsor
Baylor College of Medicine
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2001
Completion date
April 30, 2004
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

histiocytosis, langerhans-cell